Pricing
Formed in late 2017, AMLo Biosciences is dedicated to providing a prognostic test for early AJCC Stage I and Stage II melanoma to better identify patients’ true risk of disease progression.
Industries
Headquarters
Employees
Links
Full screen
Marie Labus
View all
4 people · 0 jobs
5 people · 0 jobs
HQ
0 people · 0 jobs
Peptone
2 followers
Tango Therapeutics
3 followers
FUJIFILM Diosynth Biotechnologies
17 followers
Cellares
4 followers
ContractPodAi
COMPASS Pathways
6 followers
QuellTX
Lendable
Sanofi
281 followers
Gilead Sciences
159 followers
Regeneron
130 followers
Explore companies